Spineway Future Growth
Future criteria checks 1/6
Spineway is forecast to grow earnings and revenue by 97.7% and 12.3% per annum respectively while EPS is expected to decline by 1.7% per annum.
Key information
97.7%
Earnings growth rate
-1.7%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 12.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 16 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 16 | N/A | N/A | 1 | 1 |
| 12/31/2025 | 15 | 0 | N/A | 1 | 1 |
| 12/31/2024 | 13 | -2 | N/A | -1 | 1 |
| 12/31/2023 | 11 | -7 | -6 | -6 | N/A |
| 9/30/2023 | 11 | -5 | -11 | -4 | N/A |
| 6/30/2023 | 11 | -4 | -15 | -3 | N/A |
| 3/31/2023 | 10 | -4 | -14 | -2 | N/A |
| 12/31/2022 | 9 | -3 | -14 | -2 | N/A |
| 9/30/2022 | 7 | -2 | -8 | -2 | N/A |
| 6/30/2022 | 6 | -2 | -3 | -2 | N/A |
| 3/31/2022 | 6 | -2 | -3 | -2 | N/A |
| 12/31/2021 | 5 | -2 | -3 | -2 | N/A |
| 9/30/2021 | 5 | -2 | -3 | -1 | N/A |
| 6/30/2021 | 5 | -3 | -2 | -1 | N/A |
| 3/31/2021 | 5 | -8 | -2 | -1 | N/A |
| 12/31/2020 | 5 | -14 | -1 | 0 | N/A |
| 9/30/2020 | 5 | -14 | -3 | 0 | N/A |
| 6/30/2020 | 5 | -13 | -4 | 0 | N/A |
| 3/31/2020 | 5 | -8 | -5 | -1 | N/A |
| 12/31/2019 | 6 | -3 | -6 | -1 | N/A |
| 9/30/2019 | 6 | -3 | -6 | -2 | N/A |
| 6/30/2019 | 6 | -4 | -5 | -3 | N/A |
| 3/31/2019 | 6 | -4 | -5 | -3 | N/A |
| 12/31/2018 | 7 | -4 | -4 | -3 | N/A |
| 9/30/2018 | 7 | -4 | -4 | -3 | N/A |
| 6/30/2018 | 7 | -4 | -3 | -2 | N/A |
| 3/31/2018 | 8 | -2 | -2 | -1 | N/A |
| 12/31/2017 | 10 | -1 | -2 | -1 | N/A |
| 9/30/2017 | 9 | -1 | N/A | -1 | N/A |
| 6/30/2017 | 9 | -1 | N/A | -1 | N/A |
| 3/31/2017 | 7 | -2 | N/A | -1 | N/A |
| 12/31/2016 | 5 | -3 | N/A | 0 | N/A |
| 9/30/2016 | 5 | -2 | N/A | N/A | N/A |
| 6/30/2016 | 6 | -2 | N/A | 0 | N/A |
| 3/31/2016 | 6 | -2 | N/A | 0 | N/A |
| 12/31/2015 | 6 | -2 | N/A | 0 | N/A |
| 9/30/2015 | 6 | -2 | N/A | N/A | N/A |
| 6/30/2015 | 5 | -2 | N/A | -1 | N/A |
| 3/31/2015 | 5 | -2 | N/A | -1 | N/A |
| 12/31/2014 | 5 | -2 | N/A | -2 | N/A |
| 9/30/2014 | 6 | -1 | N/A | N/A | N/A |
| 6/30/2014 | 6 | 0 | N/A | -2 | N/A |
| 3/31/2014 | 6 | 0 | N/A | -1 | N/A |
| 12/31/2013 | 7 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 37S is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 37S is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 37S is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 37S's revenue (12.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 37S's revenue (12.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 37S's Return on Equity is forecast to be high in 3 years time